Herd Immunity: Understanding COVID-19

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, COVID-19, has demonstrated the devastating impact of a novel, infectious pathogen on a susceptible population. Here, we explain the basic concepts of herd immunity and discuss its implications in the context of COVID-19.

[1]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[2]  Roy M. Anderson,et al.  Vaccination and herd immunity to infectious diseases , 1985, Nature.

[3]  D. Tyrrell,et al.  The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.

[4]  Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.

[5]  Chonggang Xu,et al.  High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Emerging infectious diseases.

[6]  M. Mirsaeidi,et al.  COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis , 2020, Frontiers in Medicine.

[7]  Y. Wen,et al.  Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.

[8]  H. Gao,et al.  Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2 , 2020, bioRxiv.

[9]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[10]  Timothy F. Leslie,et al.  Complexity of the Basic Reproduction Number (R0) , 2019, Emerging infectious diseases.

[11]  Yang Liu,et al.  Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.

[12]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[13]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[14]  M. Chan-yeung,et al.  Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance , 2006, Respirology.

[15]  Chuan Qin,et al.  Reinfection could not occur in SARS-CoV-2 infected rhesus macaques , 2020 .

[16]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.